{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:24:08Z","timestamp":1793147048067,"version":"4.5.0"},"reference-count":61,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","heartlungcirc.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Heart, Lung and Circulation"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.hlc.2019.10.013","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T21:22:13Z","timestamp":1575580933000},"page":"520-528","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) \u2013 Time to Explore the Dark Side of the Moon"],"prefix":"10.1016","volume":"29","author":[{"given":"Andreas","family":"Pflaumer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur A.M.","family":"Wilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fatme","family":"Charafeddine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew M.","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.hlc.2019.10.013_bib1","series-title":"Catecholamine-induced severe ventricular arrhythmias with Adams-Stokes syndrome in children: report of four cases","author":"Coumel","year":"1978"},{"key":"10.1016\/j.hlc.2019.10.013_bib2","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1016\/j.hlc.2018.10.016","article-title":"An update on the diagnosis and management of catecholaminergic polymorphic ventricular tachycardia","volume":"28","author":"Pflaumer","year":"2019","journal-title":"Heart Lung Circ"},{"key":"10.1016\/j.hlc.2019.10.013_bib3","doi-asserted-by":"crossref","first-page":"e77","DOI":"10.1161\/01.RES.0000169067.51055.72","article-title":"Bidirectional ventricular tachycardia and fibrillation elicited in a knock-in mouse model carrier of a mutation in the cardiac ryanodine receptor","volume":"96","author":"Cerrone","year":"2005","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2019.10.013_bib4","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1161\/01.RES.0000235869.50747.e1","article-title":"Arrhythmogenesis in catecholaminergic polymorphic ventricular tachycardia: insights from a RyR2 R4496C knock-in mouse model","volume":"99","author":"Liu","year":"2006","journal-title":"Circ Res"},{"key":"10.1016\/j.hlc.2019.10.013_bib5","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1016\/j.hrthm.2010.06.010","article-title":"Purkinje cell calcium dysregulation is the cellular mechanism that underlies catecholaminergic polymorphic ventricular tachycardia","volume":"7","author":"Herron","year":"2010","journal-title":"Heart Rhythm Journal"},{"key":"10.1016\/j.hlc.2019.10.013_bib6","first-page":"66","article-title":"Catecholaminergic polymorphic ventricular tachycardia: electrocardiographic characteristics and optimal therapeutic strategies to prevent sudden death","volume":"89","author":"Sumitomo","year":"2003"},{"key":"10.1016\/j.hlc.2019.10.013_bib7","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/j.hrthm.2011.01.048","article-title":"Arrhythmia characterization and long-term outcomes in catecholaminergic polymorphic ventricular tachycardia","volume":"8","author":"SY","year":"2011","journal-title":"Heart Rhythm Journal"},{"key":"10.1016\/j.hlc.2019.10.013_bib8","first-page":"1062","article-title":"Effects of catheter ablation targeting the trigger beats in inherited catecholaminergic polymorphic ventricular tachycardia","volume":"3","author":"Kaneshiro","year":"2017","journal-title":"JACC: Clinical Electrophysiology"},{"key":"10.1016\/j.hlc.2019.10.013_bib9","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.yjmcc.2011.05.020","article-title":"Anatomical and molecular mapping of the left and right ventricular His-Purkinje conduction networks","volume":"51","author":"Atkinson","year":"2011","journal-title":"J\u00a0Mol Cell Cardiol"},{"key":"10.1016\/j.hlc.2019.10.013_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2019.01.034","article-title":"Role of the Purkinje system in heritable arrhythmias","author":"Wilde","year":"2019","journal-title":"Heart Rhythm Journal"},{"key":"10.1016\/j.hlc.2019.10.013_bib11","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jelectrocard.2015.06.005","article-title":"Arrythmogenic right ventricular dysplasia\/cardiomyopathy (ARVD\/C) and cathecholaminergic polymorphic ventricular tachycardia (CPVT): A phenotypic spectrum seen in same patient","volume":"48","author":"Patel","year":"2015","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.hlc.2019.10.013_bib12","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jelectrocard.2016.09.006","article-title":"A\u00a0novel RYR2 loss-of-function mutation (I4855M) is associated with left ventricular non-compaction and atypical catecholaminergic polymorphic ventricular tachycardia","volume":"50","author":"Roston","year":"2017","journal-title":"Journal of Electrocardiology"},{"key":"10.1016\/j.hlc.2019.10.013_bib13","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.hrthm.2018.08.025","article-title":"Linking the heart and the brain: Neurodevelopmental disorders in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"16","author":"Lieve","year":"2019","journal-title":"Heart Rhythm Journal"},{"key":"10.1016\/j.hlc.2019.10.013_bib14","first-page":"2230","article-title":"Leaky Ca2+ release channel\/ryanodine receptor 2 causes seizures and sudden cardiac death in mice","volume":"118","author":"Lehnart","year":"2008","journal-title":"J\u00a0Clin Invest"},{"key":"10.1016\/j.hlc.2019.10.013_bib15","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.seizure.2019.02.017","article-title":"Ryanodine receptor 2 (RYR2) mutation: A potentially novel neurocardiac calcium channelopathy manifesting as primary generalised epilepsy","volume":"67","author":"Yap","year":"2019","journal-title":"Seizure"},{"key":"10.1016\/j.hlc.2019.10.013_bib16","doi-asserted-by":"crossref","DOI":"10.2169\/internalmedicine.9843-17","article-title":"Bradycardia is a specific phenotype of catecholaminergic polymorphic ventricular tachycardia induced by RYR2 mutations","author":"Miyata","year":"2018","journal-title":"Intern Med"},{"key":"10.1016\/j.hlc.2019.10.013_bib17","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1161\/CIRCEP.112.970517","article-title":"Familial evaluation in catecholaminergic polymorphic ventricular tachycardia: disease penetrance and expression in cardiac ryanodine receptor mutation-carrying relatives","volume":"5","author":"van der Werf","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hlc.2019.10.013_bib18","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1161\/CIRCEP.114.002217","article-title":"Catecholaminergic polymorphic ventricular tachycardia in children: analysis of therapeutic strategies and outcomes from an international multicenter registry","volume":"8","author":"Roston","year":"2015","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hlc.2019.10.013_bib19","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1093\/europace\/euw389","article-title":"The clinical and genetic spectrum of catecholaminergic polymorphic ventricular tachycardia: findings from an international multicentre registry","volume":"20","author":"Roston","year":"2018","journal-title":"Europace"},{"key":"10.1016\/j.hlc.2019.10.013_bib20","article-title":"Nationwide experience of catecholaminergic polymorphic ventricular tachycardia caused by RyR2 mutations","author":"Broendberg","year":"2017","journal-title":"Br Heart J"},{"key":"10.1016\/j.hlc.2019.10.013_bib21","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1253\/circj.71.1606","article-title":"Association of atrial arrhythmia and sinus node dysfunction in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"71","author":"Sumitomo","year":"2007","journal-title":"Circ J"},{"key":"10.1016\/j.hlc.2019.10.013_bib22","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1161\/CIRCEP.112.973230","article-title":"Epinephrine infusion in the evaluation of unexplained cardiac arrest and familial sudden death: from the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry","volume":"5","author":"Krahn","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hlc.2019.10.013_bib23","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCEP.115.004274","article-title":"Cardiac abnormalities in first-degree relatives of unexplained cardiac arrest victims: A report from the Cardiac Arrest Survivors With Preserved Ejection Fraction Registry","volume":"9","author":"Steinberg","year":"2016","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hlc.2019.10.013_bib24","doi-asserted-by":"crossref","first-page":"1932","DOI":"10.1016\/j.hrthm.2013.05.014","article-title":"HRS\/EHRA\/APHRS expert consensus statement on the diagnosis and management of patients with inherited primary arrhythmia syndromes: document endorsed by HRS, EHRA, and APHRS in May 2013 and by ACCF, AHA, PACES, and AEPC in June 2013","volume":"10","author":"Priori","year":"2013","journal-title":"Heart Rhythm Journal"},{"key":"10.1016\/j.hlc.2019.10.013_bib25","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1161\/CIRCGENETICS.111.962316","article-title":"Phenotype variability in patients carrying KCNJ2 mutations","volume":"5","author":"Kimura","year":"2012","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hlc.2019.10.013_bib26","article-title":"Different responses to exercise between Andersen-Tawil syndrome and catecholaminergic polymorphic ventricular tachycardia","author":"Inoue","year":"2017","journal-title":"Europace"},{"key":"10.1016\/j.hlc.2019.10.013_bib27","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijcard.2017.01.113","article-title":"Gain-of-function mutation in SCN5A causes ventricular arrhythmias and early onset atrial fibrillation","volume":"236","author":"Lieve","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/j.hlc.2019.10.013_bib28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1161\/CIRCGENETICS.114.000703","article-title":"Gain-of-function mutation of the SCN5A gene causes exercise-induced polymorphic ventricular arrhythmias","volume":"7","author":"Swan","year":"2014","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/j.hlc.2019.10.013_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2018.02.006","article-title":"Mutation-linked, excessively tight interaction between the calmodulin binding domain and the C-terminal domain of the cardiac ryanodine receptor as a novel cause of catecholaminergic polymorphic ventricular tachycardia","author":"Nishimura","year":"2018","journal-title":"Heart Rhythm Journal"},{"key":"10.1016\/j.hlc.2019.10.013_bib30","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz311","article-title":"Calmodulin mutations and life-threatening cardiac arrhythmias: insights from the International Calmodulinopathy Registry","author":"Crotti","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2019.10.013_bib31","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1016\/j.hrthm.2017.07.032","article-title":"The evolving role of ankyrin-B in cardiovascular disease","volume":"14","author":"Koenig","year":"2017","journal-title":"Heart Rhythm Journal"},{"key":"10.1016\/j.hlc.2019.10.013_bib32","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.15252\/emmm.201505719","article-title":"TECRL, a new life-threatening inherited arrhythmia gene associated with overlapping clinical features of both LQTS and CPVT","volume":"8","author":"Devalla","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/j.hlc.2019.10.013_bib33","first-page":"120","article-title":"Plakophilin-2 truncation variants in patients clinically diagnosed with catecholaminergic polymorphic ventricular tachycardia and\u00a0descendents with exercise-associated autopsy negative sudden unexplained death in the young","volume":"5","author":"Tester","year":"2019","journal-title":"JACC: Clinical Electrophysiology"},{"key":"10.1016\/j.hlc.2019.10.013_bib34","doi-asserted-by":"crossref","first-page":"e001424","DOI":"10.1161\/CIRCGEN.116.001424","article-title":"Yield of the RYR2 genetic test in suspected catecholaminergic polymorphic ventricular tachycardia and implications for test interpretation","volume":"11","author":"Kapplinger","year":"2018","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.hlc.2019.10.013_bib35","doi-asserted-by":"crossref","first-page":"e002510","DOI":"10.1161\/CIRCGEN.119.002510","article-title":"assessment and validation of a phenotype-enhanced variant classification framework to promote or demote RYR2 missense variants of uncertain significance","volume":"12","author":"Giudicessi","year":"2019","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/j.hlc.2019.10.013_bib36","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.hrthm.2015.09.029","article-title":"Nadolol decreases the incidence and severity of ventricular arrhythmias during exercise stress testing compared with \u03b21-selective \u03b2-blockers in patients with catecholaminergic polymorphic ventricular tachycardia","volume":"13","author":"Leren","year":"2016","journal-title":"Heart Rhythm Journal"},{"key":"10.1016\/j.hlc.2019.10.013_bib37","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1016\/j.hrthm.2016.09.012","article-title":"Beta-blocker therapy for long QT syndrome and catecholaminergic polymorphic ventricular tachycardia: Are all beta-blockers equivalent?","volume":"14","author":"Ackerman","year":"2017","journal-title":"Heart Rhythm Journal"},{"key":"10.1016\/j.hlc.2019.10.013_bib38","first-page":"1308","article-title":"Circadian variation of ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia","volume":"3","author":"Miyake","year":"2017","journal-title":"JACC: Clinical Electrophysiology"},{"key":"10.1016\/j.hlc.2019.10.013_bib39","doi-asserted-by":"crossref","first-page":"2426","DOI":"10.1161\/CIRCULATIONAHA.108.829267","article-title":"Incidence and risk factors of arrhythmic events in catecholaminergic polymorphic ventricular tachycardia","volume":"119","author":"Hayashi","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2019.10.013_bib40","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1001\/jamacardio.2017.1320","article-title":"Efficacy of flecainide in the treatment of catecholaminergic polymorphic ventricular tachycardia: A randomized clinical trial","volume":"2","author":"Kannankeril","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.hlc.2019.10.013_bib41","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1161\/CIRCULATIONAHA.115.015731","article-title":"Clinical management of catecholaminergic polymorphic ventricular tachycardia: The role of left cardiac sympathetic denervation","volume":"131","author":"De Ferrari","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2019.10.013_bib42","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1111\/pace.13668","article-title":"A\u00a0large deletion in RYR2 exon 3 is associated with nadolol and flecainide refractory catecholaminergic polymorphic ventricular tachycardia","volume":"42","author":"Kohli","year":"2019","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hlc.2019.10.013_bib43","doi-asserted-by":"crossref","first-page":"e0207100","DOI":"10.1371\/journal.pone.0207100","article-title":"Arrhythmia initiation in catecholaminergic polymorphic ventricular tachycardia type 1 depends on both heart rate and sympathetic stimulation","volume":"13","author":"Danielsen","year":"2018","journal-title":"PLoS ONE"},{"key":"10.1016\/j.hlc.2019.10.013_bib44","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1111\/pace.13446","article-title":"Efficacy of ivabradine to control ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia","volume":"41","author":"Vaksmann","year":"2018","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hlc.2019.10.013_bib45","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1161\/CIRCEP.113.000170","article-title":"Efficacy of implantable cardioverter defibrillators in young patients with catecholaminergic polymorphic ventricular tachycardia: success depends on substrate","volume":"6","author":"Miyake","year":"2013","journal-title":"Circ Arrhythm Electrophysiol"},{"key":"10.1016\/j.hlc.2019.10.013_bib46","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz309","article-title":"Implantable cardioverter-defibrillators in previously undiagnosed patients with catecholaminergic polymorphic ventricular tachycardia resuscitated from sudden cardiac arrest","author":"van der Werf","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/j.hlc.2019.10.013_bib47","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.hrthm.2013.10.027","article-title":"Outcomes of defibrillator therapy in catecholaminergic polymorphic ventricular tachycardia","volume":"11","author":"Roses-Noguer","year":"2014","journal-title":"Heart Rhythm Journal"},{"key":"10.1016\/j.hlc.2019.10.013_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.hrthm.2018.06.046","article-title":"Implantable cardioverter-defibrillator use in catecholaminergic polymorphic ventricular tachycardia: A systematic review","author":"Roston","year":"2018","journal-title":"Heart Rhythm Journal"},{"key":"10.1016\/j.hlc.2019.10.013_bib49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/s12265-014-9541-0","article-title":"Left cardiac sympathetic denervation in patients with heart failure: a new indication for an old intervention?","volume":"7","author":"De Ferrari","year":"2014","journal-title":"J\u00a0of Cardiovasc Trans Res"},{"key":"10.1016\/j.hlc.2019.10.013_bib50","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s00392-012-0492-7","article-title":"Left cardiac sympathetic denervation for the management of life-threatening ventricular tachyarrhythmias in young patients with catecholaminergic polymorphic ventricular tachycardia and long QT syndrome","volume":"102","author":"Schneider","year":"2013","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/j.hlc.2019.10.013_bib51","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1111\/pace.13006","article-title":"Elimination of ventricular arrhythmia in catecholaminergic polymorphic ventricular tachycardia by targeting \u201ccatecholamine-sensitive area\u201d: A dominant-subordinate relationship between origin sites of bidirectional ventricular premature contractions","volume":"40","author":"Shirai","year":"2017","journal-title":"Pacing Clin Electrophysiol"},{"key":"10.1016\/j.hlc.2019.10.013_bib52","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1253\/circj.CJ-16-0250","article-title":"Catecholaminergic polymorphic ventricular tachycardia (CPVT) associated with ryanodine teceptor (RyR2) gene mutations\u2013long-term prognosis after initiation of medical treatment","volume":"80","author":"Kawata","year":"2016","journal-title":"Circ J"},{"key":"10.1016\/j.hlc.2019.10.013_bib53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.jccase.2018.09.004","article-title":"Radiofrequency catheter ablation for drug-refractory atrial tachyarrhythmias in a patient with catecholaminergic polymorphic ventricular tachycardia: A case report","volume":"19","author":"Kawada","year":"2019","journal-title":"J\u00a0Cardiol Cases"},{"key":"10.1016\/j.hlc.2019.10.013_bib54","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1097\/PCC.0000000000001847","article-title":"Catecholaminergic polymorphic ventricular tachycardia: The cardiac arrest where epinephrine is contraindicated","volume":"20","author":"Bellamy","year":"2019","journal-title":"Pediatr Crit Care Med"},{"key":"10.1016\/j.hlc.2019.10.013_bib55","first-page":"253","article-title":"Competitive sports participation in patients with catecholaminergic polymorphic ventricular tachycardia: A single center's early experience","volume":"2","author":"Ostby","year":"2016","journal-title":"JACC: Clinical Electrophysiology"},{"key":"10.1016\/j.hlc.2019.10.013_bib56","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.hrthm.2017.12.020","article-title":"Exercise participation and shared decision-making in patients with inherited channelopathies and cardiomyopathies","volume":"15","author":"Etheridge","year":"2018","journal-title":"Heart Rhythm"},{"key":"10.1016\/j.hlc.2019.10.013_bib57","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1161\/CIRCULATIONAHA.113.006901","article-title":"Single delivery of an adeno-associated viral construct to transfer the CASQ2 gene to knock-in mice affected by catecholaminergic polymorphic ventricular tachycardia is able to cure the disease from birth to advanced age","volume":"129","author":"Denegri","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.hlc.2019.10.013_bib58","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/j.hrthm.2017.03.025","article-title":"Viral delivered gene therapy to treat catecholaminergic polymorphic ventricular tachycardia (CPVT2) in mouse models","volume":"14","author":"Kurtzwald-Josefson","year":"2017","journal-title":"Heart Rhythm Journal"},{"key":"10.1016\/j.hlc.2019.10.013_bib59","article-title":"Gene transfer of engineered calmodulin alleviates ventricular arrhythmias in a calsequestrin-associated mouse model of catecholaminergic polymorphic ventricular tachycardia","volume":"7","author":"Liu","year":"2018","journal-title":"J\u00a0Am Heart Assoc"},{"key":"10.1016\/j.hlc.2019.10.013_bib60","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ceca.2018.04.009","article-title":"CRISPR\/Cas9 Gene editing of RyR2 in human stem cell-derived cardiomyocytes provides a novel approach in investigating dysfunctional Ca2+ signaling","volume":"73","author":"Wei","year":"2018","journal-title":"Cell Calcium"},{"key":"10.1016\/j.hlc.2019.10.013_bib61","doi-asserted-by":"crossref","first-page":"17514","DOI":"10.1038\/s41598-017-17819-8","article-title":"An optogenetic arrhythmia model to study catecholaminergic polymorphic ventricular tachycardia mutations","volume":"7","author":"Fischer","year":"2017","journal-title":"Sci Rep"}],"container-title":["Heart, Lung and Circulation"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950619315161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1443950619315161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,25]],"date-time":"2025-10-25T18:00:02Z","timestamp":1761415202000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1443950619315161"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":61,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S1443950619315161"],"URL":"https:\/\/doi.org\/10.1016\/j.hlc.2019.10.013","relation":{},"ISSN":["1443-9506"],"issn-type":[{"value":"1443-9506","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"50 Years of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) \u2013 Time to Explore the Dark Side of the Moon","name":"articletitle","label":"Article Title"},{"value":"Heart, Lung and Circulation","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.hlc.2019.10.013","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Australian and New Zealand Society of Cardiac and Thoracic Surgeons (ANZSCTS) and the Cardiac Society of Australia and New Zealand (CSANZ). Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}